Patient P-02015

Synthetic patientMETA-24 · Day 93 · 35–44 · F · baseline S14Steering view · 3D Open companion preview

Therapy response

Declining

Tolerance

Favorable

GI state

Improving

Inflammatory state

Favorable

Nutritional resilience

Stable

Discontinuation risk

24%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S14

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

GI instability-6
Treatment adherence+5
Inflammatory activity-3
Toxicity+2

What helped?

No interventions yet.

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

60 min

worsening · -4.2 vs previous 14 d

Sleep duration

Wearable

6.7 h

stable · -0.2 vs previous 14 d

Energy level

Daily log

6.8/10

worsening · -0.3 vs previous 14 d

Steps

Wearable

6,497

worsening · -455 vs previous 14 d

GI burden

Companion

26.1/100

worsening · +8.3 vs previous 14 d

Adherence

Companion

94.6 %

stable · -3.0 vs previous 14 d

Sleep quality

Wearable

33.2/100

worsening · -2.9 vs previous 14 d

Glucose, CGM daily mean

CGM

128 mg/dL

stable · +5.1 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 79 from the failing basin, 10 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -5.1 next day on high-intake days · n 20

Would not help

Keep alcohol low
GI +4.9 next day on high-intake days · n 19
Keep caffeine low
GI +4.4 next day on high-intake days · n 18

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-5.1supporter · 95%
Alcohol
+4.9detractor · 95%
Caffeine
+4.4detractor · 95%
Insoluble fibre
+1.6no signal · 30%
Ultra-processed food
+1.2no signal · 23%
Dietary fat load
-1.1no signal · 21%
Histamine load
-0.9no signal · 22%
Simple carbohydrates
+0.2no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Drug metabolism and exposure ↑40
- DNACYP2D6 poor metabolizer → higher exposure
Inflammatory signalling ↓35
- MicrobiomeBacteroides fragilis expansion
- WearableHRV 36 ms, trending down
Butyrate / short-chain fatty acid production ↓25
- MicrobiomeF. prausnitzii depleted
Autonomic recovery ↑25
- WearableResting HR 74 bpm

DNA

Fictional pharmacogenomic panel

CYP2D6 Poor metabolizer
Higher exposure at standard dose
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 3.3 · butyrate capacity 75/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiLow
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 35 ms
Sleep: 6.6 h
Steps: 5,140
Resting HR: 74 bpm

Daily log: GI score 26, nutritional resilience 59, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Add one soluble-fibre source (oats, cooked carrots, banana) to breakfast
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02555	44%	S01	AD-05	no change	79
P-02277	38%	S05	AD-05	improved	92
P-02013	43%	S14	BR-03	no change	94
P-02282	41%	S01	BR-03	no change	88
P-02193	37%	S11	CR-01	improved	87
P-02354	34%	S01	CR-01	improved	78
P-02081	48%	S20	DT-01	no change	88
P-02565	41%	S09	DT-01	no change	79
P-02249	33%	S09	DT-01	improved	100
P-02337	32%	S18	DT-01	no change	100
P-02518	32%	S17	DT-01	improved	68
P-02462	31%	S12	DT-01	improved	65